Health Catalyst Q3 2023 Earnings Report

Health Catalyst EPS Results

• Actual EPS: -$0.22
• Consensus EPS: -$0.27
• Beat/Miss: Beat by +$0.05
• One Year Ago EPS: N/A

Health Catalyst Revenue Results

• Actual Revenue: $73.77 million
• Expected Revenue: $72.73 million
• Beat/Miss: Beat by +$1.04 million
• YoY Revenue Growth: N/A

Health Catalyst Announcement Details

• Quarter: Q3 2023
• Date: 11/2/2023
• Time: N/A

Health Catalyst (NASDAQ:HCAT) provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.